Keyphrases
Adenocarcinoma
100%
Node-positive
100%
Duodenum
100%
Local Control
100%
Concurrent Chemoradiation
100%
5-year Survival
75%
Pancreaticoduodenectomy
75%
Median Survival
75%
Adjuvant Chemoradiation
75%
Duodenal Adenocarcinoma
75%
Distant Metastasis
50%
Historical Controls
50%
Surgery Alone
50%
Chemoradiation Therapy
50%
Recurrent Disease
25%
Plan Comparison
25%
Johns Hopkins Hospital
25%
Retrospective Review
25%
Radiation Dose
25%
Radiation Therapy
25%
Referral Center
25%
Periampullary Cancer
25%
Local Recurrence
25%
First Recurrence
25%
Fluoropyrimidine-based Chemotherapy
25%
Adjuvant Chemoradiotherapy
25%
Maintenance Chemotherapy
25%
Local Survival
25%
Local Median
25%
Medicine and Dentistry
Adenocarcinoma
100%
Chemoradiotherapy
100%
Duodenum
100%
Recurrent Disease
75%
Pancreaticoduodenectomy
75%
Distant Metastasis
50%
Chemoradiation Therapy
50%
Survival Rate
25%
Carcinoma
25%
Patient Referral
25%
Overall Survival
25%
Fluorouracil
25%
Adjuvant Chemoradiotherapy
25%
Maintenance Chemotherapy
25%
Radiation Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
100%
Chemoradiation Therapy
100%
Recurrent Disease
60%
Chemotherapy
40%
Distant Metastasis
40%
Carcinoma
20%
Survival Rate
20%
Overall Survival
20%
Fluorouracil
20%